semaglutide face changes “Ozempic” and Implications in Cosmetic Dermatology - Montecinos - 2024 - Dermatological Reviews GLP-1 medications (like semaglutide and

In March 2025, Novo said it agreed to pay up to $2 billion for the rights to an early experimental drug from the Chinese pharmaceutical company United Laboratories International

Ashwagandha may increase your risk of liver damage when taken with medications that can cause liver damage, particularly with chronic use

Gutgesell RM, Nogueiras R, Tschp MH, Mller TD

These findings suggest that GHK may enhance the regenerative potential of various cell types by increasing their proliferative capacity

If youre willing to consider injections, lasers, and microneedling, there are a ton more treatment options - and again, the best one will be different for each person, based on their needs

As of this writing, CagriSema has an NDA filed with the FDA as of late 2025, with a review expected sometime in 2026